CD274 and neoplasm: Chemotherapy, PARPi and radiotherapy, as monotherapies or combined, might either enhance cytotoxic T lymphocytes against tumor cells or induce immunosuppressive effects through up-regulation of PD-L1 (also known as CD274) [12,13].